Wen Ya Huang

Title: Innovations by Wen Ya Huang in Hepatitis B Virus Research

Introduction

Wen Ya Huang is a notable inventor based in Tainan, Taiwan. He has made significant contributions to the field of medical research, particularly in the study of hepatitis B virus (HBV) and chronic liver diseases. His innovative work has led to the development of a unique kit that enhances the detection and analysis of HBV.

Latest Patents

Wen Ya Huang holds a patent for a kit designed for in vitro quantifying large surface protein of hepatitis B virus (LHBS). This kit includes monoclonal antibodies that have specific binding affinities for various regions of LHBS. The invention aims to increase the sensitivity and dynamic range of detecting LHBS in biological samples. Additionally, it provides a biomarker set that can be recognized by these monoclonal antibodies, facilitating non-invasive analysis of HBV infection phases and hepatoma prognosis. Furthermore, the kit offers a set of monoclonal antibodies that can predict, diagnose, or treat chronic liver diseases in patients.

Career Highlights

Wen Ya Huang is affiliated with National Cheng Kung University, where he continues to advance his research in virology and immunology. His work has garnered attention for its potential impact on diagnosing and treating liver diseases, which are significant health concerns worldwide.

Collaborations

Wen Ya Huang collaborates with esteemed colleagues, including Chia Jui Yen and Yun-Ping Lee, who contribute to his research endeavors. Their combined expertise enhances the quality and scope of their projects.

Conclusion

Wen Ya Huang's innovative contributions to hepatitis B virus research exemplify the importance of scientific advancements in healthcare. His patented kit represents a significant step forward in the detection and treatment of chronic liver diseases.